tag:blogger.com,1999:blog-5006185839221031362.post8242516287601049212..comments2023-09-15T16:54:53.401+02:00Comments on HEALTH ECONOMICS BLOG - Trends, Politics, Opinions etc. in biotech & pharma industry: Spain - yet another Royal Decree to cut costsUnknownnoreply@blogger.comBlogger3125tag:blogger.com,1999:blog-5006185839221031362.post-43253488191767633252012-08-13T08:34:45.441+02:002012-08-13T08:34:45.441+02:00The pharmaceutical industry is under mounting scru...The pharmaceutical industry is under mounting scrutiny because of rapidly increasing expenditures for drugs worldwide.Drug expenditures are now the fastest-growing component of health care costs, increasing at the rate of about 15 percent per year.Above report provides important information related to china healthcare industry and it's current situation..Thnx for sharing this useful informationIndustry Research Reportshttp://www.bharatbook.com/noreply@blogger.comtag:blogger.com,1999:blog-5006185839221031362.post-83985927677463532552012-05-16T10:18:17.958+02:002012-05-16T10:18:17.958+02:00I agree with you that certain elements are importa...I agree with you that certain elements are important of course, generics free up resources for new, innovative medicines. What is the issue is that the process for nerw medicines is not clear and very intransparent and slow. Uniformity will probably never be achieved, however clarity on assessment criteria and process can and should be achieved.ustaginnus@hotmail.comhttps://www.blogger.com/profile/13405997204504599670noreply@blogger.comtag:blogger.com,1999:blog-5006185839221031362.post-51812403425569559572012-05-10T22:17:19.549+02:002012-05-10T22:17:19.549+02:00Spain is working hard to cut costs, and the increa...Spain is working hard to cut costs, and the increase in generics will be important. Moreover, until there is actual uniformity across the Autonomous Regions, it remains a complicated landscape!Anonymousnoreply@blogger.com